Feifei She

1.0k total citations
46 papers, 812 citations indexed

About

Feifei She is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Feifei She has authored 46 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 22 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Feifei She's work include Helicobacter pylori-related gastroenterology studies (17 papers), Veterinary medicine and infectious diseases (9 papers) and Galectins and Cancer Biology (9 papers). Feifei She is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (17 papers), Veterinary medicine and infectious diseases (9 papers) and Galectins and Cancer Biology (9 papers). Feifei She collaborates with scholars based in China, Canada and Saudi Arabia. Feifei She's co-authors include Yanling Chen, Xiaoqian Wang, Neng Li, Qiang Du, Lei Jiang, Haijie Hong, Nanhong Tang, Xiujin Li, Guangwei Zhu and Xiaoyan Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Feifei She

46 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei She China 17 336 332 245 231 190 46 812
Acacia Lamb United States 10 516 1.5× 376 1.1× 399 1.6× 220 1.0× 265 1.4× 12 1.1k
Emilie Bessède France 18 411 1.2× 538 1.6× 170 0.7× 243 1.1× 168 0.9× 38 1.1k
Gloria Fernández‐Tilapa Mexico 18 310 0.9× 305 0.9× 161 0.7× 65 0.3× 275 1.4× 34 784
Nobumi Suzuki Japan 16 303 0.9× 311 0.9× 127 0.5× 216 0.9× 94 0.5× 49 806
Atsushi Azuma Japan 16 453 1.3× 251 0.8× 172 0.7× 200 0.9× 52 0.3× 22 876
Yaovalux Chamgramol Thailand 15 316 0.9× 325 1.0× 53 0.2× 202 0.9× 175 0.9× 34 683
Lisa D. Berman-Booty United States 12 336 1.0× 103 0.3× 289 1.2× 155 0.7× 158 0.8× 21 844
Sozaburo Ihara Japan 17 329 1.0× 214 0.6× 176 0.7× 169 0.7× 68 0.4× 38 795
Hironobu Nakano Japan 8 316 0.9× 285 0.9× 215 0.9× 68 0.3× 42 0.2× 12 701
Stephan Kießling Germany 10 600 1.8× 197 0.6× 459 1.9× 227 1.0× 102 0.5× 17 1.2k

Countries citing papers authored by Feifei She

Since Specialization
Citations

This map shows the geographic impact of Feifei She's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei She with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei She more than expected).

Fields of papers citing papers by Feifei She

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei She. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei She. The network helps show where Feifei She may publish in the future.

Co-authorship network of co-authors of Feifei She

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei She. A scholar is included among the top collaborators of Feifei She based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei She. Feifei She is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huang‐Yu, Chu Chen, Hongyu Yan, et al.. (2024). High salt condition alters LPS synthesis and induces the emergence of drug resistance mutations in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 68(10). e0058724–e0058724. 2 indexed citations
2.
She, Feifei, et al.. (2024). SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics. Journal of Biochemical and Molecular Toxicology. 38(6). e23733–e23733. 4 indexed citations
3.
Chen, Weihong, et al.. (2024). M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Experimental Hematology and Oncology. 13(1). 83–83. 14 indexed citations
4.
Zhang, Xiaoyan, et al.. (2023). Role of AlgC and GalU in the Intrinsic Antibiotic Resistance of Helicobacter pylori. Infection and Drug Resistance. Volume 16. 1839–1847. 3 indexed citations
5.
Zhang, Lei, et al.. (2023). IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation. Scientific Reports. 13(1). 18711–18711. 9 indexed citations
6.
Chen, Ming‐Yuan, et al.. (2023). CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. Frontiers in Oncology. 13. 1156177–1156177. 6 indexed citations
7.
8.
Xu, Xiaohong, et al.. (2021). The Role of a Dipeptide Transporter in the Virulence of Human Pathogen, Helicobacter pylori. Frontiers in Microbiology. 12. 633166–633166. 9 indexed citations
9.
Chen, Chu, Qingfeng Yi, Xiaoyan Zhang, et al.. (2020). N-terminal region of Helicobacter pylori CagA induces IL-8 production in gastric epithelial cells via the β1 integrin receptor. Journal of Medical Microbiology. 69(3). 457–464. 12 indexed citations
10.
Zhang, Xiaoyan, et al.. (2019). <p>A Newly Discovered Drug Resistance Gene <em>rfaF</em> In <em>Helicobacter pylori</em></p>. Infection and Drug Resistance. Volume 12. 3507–3514. 8 indexed citations
11.
Jiang, Xiaojie, Chengzong Li, Bin Lin, et al.. (2017). cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF‐κB pathway. Cancer Science. 108(6). 1144–1156. 30 indexed citations
12.
Tong, Mengying, Qirui Liang, You Guo, et al.. (2017). Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells. The Pharmacogenomics Journal. 18(1). 23–28. 33 indexed citations
13.
Lin, Bin, Haijie Hong, Xiaojie Jiang, et al.. (2017). WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival. Gene. 622. 42–49. 15 indexed citations
14.
Hong, Haijie, Lei Jiang, Guangwei Zhu, et al.. (2016). TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. BMC Cancer. 16(1). 240–240. 44 indexed citations
15.
Wang, Junwei, Xiaoqian Wang, Nanhong Tang, Yanling Chen, & Feifei She. (2015). Impact of Helicobacter pylori on the growth of hepatic orthotopic graft tumors in mice. International Journal of Oncology. 47(4). 1416–1428. 3 indexed citations
16.
Zhu, Guangwei, Hua Jin, Zhijian Wang, Feifei She, & Yanling Chen. (2015). Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies. Molecular and Clinical Oncology. 3(3). 613–618. 6 indexed citations
17.
Zhu, Guangwei, Xiao Chen, Xiaoqian Wang, et al.. (2014). Expression of the RIP-1 Gene and its Role in Growth and Invasion of Human Gallbladder Carcinoma. Cellular Physiology and Biochemistry. 34(4). 1152–1165. 29 indexed citations
18.
Lin, Wansong, et al.. (2011). Hepatitis B virus X protein enhances activation of nuclear factor κB through interaction with valosin-containing protein. Archives of Virology. 156(11). 2015–2021. 18 indexed citations
19.
Chen, Yanling, Lei Jiang, Feifei She, et al.. (2010). Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Molecular and Cellular Biochemistry. 345(1-2). 77–89. 42 indexed citations
20.
She, Feifei, Xu Lin, & Hao Chen. (2009). Helicobacter pylori oipA gene switch status and its association with gastic diseases. Zhonghua xiaohua zazhi. 29(2). 122–125. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Acacia Lamb Breakdown of academic impact, for papers by Emilie Bessède Breakdown of academic impact, for papers by Gloria Fernández‐Tilapa Breakdown of academic impact, for papers by Nobumi Suzuki Breakdown of academic impact, for papers by Atsushi Azuma Breakdown of academic impact, for papers by Yaovalux Chamgramol Breakdown of academic impact, for papers by Lisa D. Berman-Booty Breakdown of academic impact, for papers by Sozaburo Ihara Breakdown of academic impact, for papers by Hironobu Nakano Breakdown of academic impact, for papers by Stephan Kießling
Rankless by CCL
2026